[1]
Güleç Yılmaz, S. et al. 2021. The Role of Kallikrein10 (KLK10) Polymorphism in Prostate Cancer Susceptibility: KLK10 polymorphism in Prostate Cancer. Urology Journal. 19, 01 (May 2021), 41–44. DOI:https://doi.org/10.22037/uj.v19i01.6425.